Advertisement

Indian Journal of Surgical Oncology

, Volume 6, Issue 1, pp 63–68 | Cite as

Borderline Resectable Pancreatic Cancer

  • Bhargava Mullapudi
  • Patrick J. Hawkes
  • Asish Patel
  • Chandrakanth Are
  • Subhasis MisraEmail author
Review Article
  • 120 Downloads

Abstract

Borderline resectable pancreatic cancer (BRPC) is an evolving diagnostic entity that blurs the distinction between resectable and locally advanced pancreatic cancer (Varadhachary et al. Ann Surg Oncol 13:1035–1046, 2006). Until recently the management of this disease has been poorly defined; however, consensus guidelines have been developed regarding the proper management of this diagnostic entity. Recent studies have shown that if appropriately identified and treated, this subset of disease can have outcomes similar to pancreatic cancer that is defined as resectable (Laurence et al. J Gastrointest Surg 15:2059–2069, 2011). The aim of this review is to outline the current consensus on definitions, workup and management of BRPC, and also provide a summary of issues that require progress as defined by the International Study Group of Pancreatic Surgery (ISGPS).

Keywords

Borderline Pancreatic cancer Pancreas Whipple Pancreaticoduodenectomy 

References

  1. 1.
    Laurence JM, Tran PD, Morarji K, Eslick GD, Lam VW, Sandroussi C (2011) A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. J Gastrointest Surg 15:2059–2069CrossRefPubMedGoogle Scholar
  2. 2.
    Cancer Facts and Figures 2014. American Cancer Society. Available at http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf
  3. 3.
    Bockhorn M, Uzunoglu FG, Adham M et al (2014) Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 155(6):977–988CrossRefPubMedGoogle Scholar
  4. 4.
    Raimondi S, Maisonneuve P, Lowenfels AB (2009) Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 6(12):699–708CrossRefPubMedGoogle Scholar
  5. 5.
    Talamonti M (2006) Borderline resectable pancreatic cancer: a new classification for an old challenge. Ann Surg Oncol 13(8):1019–1020CrossRefPubMedGoogle Scholar
  6. 6.
    Springett GM, Hoffe SE (2008) Borderline resectable pancreatic cancer: on the edge of survival. Cancer Control 15(4):295–307PubMedGoogle Scholar
  7. 7.
    National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Pancreatic Adenocarcinoma, v.2.2014. Available at http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf
  8. 8.
    Takeshita K, Furui S, Takada K (2002) Multidetector row helical CT of the pancreas: value of three-dimensional images, two-dimensional reformations, and contrast-enhanced multiphasic imaging. J Hepato-Biliary-Pancreat Surg 9(5):576–582CrossRefGoogle Scholar
  9. 9.
    Croome KP, Jayaraman S, Schlachta CM (2010) Preoperative staging of cancer of the pancreatic head: is there room for improvement? Can J Surg 53(3):171–174PubMedCentralPubMedGoogle Scholar
  10. 10.
    Horton KM, Fishman EK (2002) Adenocarcinoma of the pancreas: CT imaging. Radiol Clin N Am 40(6):1263–1272CrossRefPubMedGoogle Scholar
  11. 11.
    Turner BG, Cizginer S, Agarwal D, Yang J, Pitman MB, Brugge WR (2010) Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc 71(1):91–98CrossRefPubMedGoogle Scholar
  12. 12.
    Fang CH, Chen XW, Ju BL (2005) Value of magnetic resonance angiography combined with magnetic resonance cholangiopancreatography on diagnosis for patients with carcinoma of head of pancreas. ZhonghuaWaiKeZaZhi 43(21):1379–1382, ChineseGoogle Scholar
  13. 13.
    Zhong L, Li L, Yao Q-Y (2005) Preoperative evaluation of pancreaticobiliary tumor using MR multi-imaging techniques. World J Gastroenterol 11(24):3756–3761CrossRefPubMedCentralPubMedGoogle Scholar
  14. 14.
    Ishikawa O, Ohigashi H, Imaoka S, Furukawa H, Sasaki Y, Fujita M, Kuroda C, Iwanaga T (1992) Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 215(3):231–236CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Micames C, Jowell PS, White R, Paulson E, Nelson R, Morse M et al (2003) Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc 58(5):690–695CrossRefPubMedGoogle Scholar
  16. 16.
    Ahmad NA, Lewis JD, Siegelman ES, Rosato EF, Ginsberg GG, Kochman ML (2000) Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma. Am J Gastroenterol 95(8):1926–1931CrossRefPubMedGoogle Scholar
  17. 17.
    Buscall L, Pages P, Berthelemy P, Fourtanier G, Frexinos J, Escourrou J (1999) Role of EUS in the management of pancreatic and ampullary carcinoma: a prospective study assessing resectability and prognosis. Gastrointest Endosc 50(1):34–40CrossRefGoogle Scholar
  18. 18.
    Cahn M, Chang K, Nguyen P, Butler J (1996) Impact of endoscopic ultrasound with fine-needle aspiration on the surgical management of pancreatic cancer. Am J Surg 172(5):470–472CrossRefPubMedGoogle Scholar
  19. 19.
    Raut CP, Grau AM, Staerkel GA et al (2003) Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 7(1):118–128CrossRefPubMedGoogle Scholar
  20. 20.
    Adham M, Mirza DF, Chapuis F, Mayer AD, Bramhall SR, Coldham C et al (2006) Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors. HPB (Oxford) 8:465–473CrossRefGoogle Scholar
  21. 21.
    Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK et al (2004) Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8:935–949, discussion 949–50CrossRefPubMedGoogle Scholar
  22. 22.
    Fuhrman GM, Leach SD, Staley CA, Cusack JC, Charnsangavej C, Cleary KR et al (1996) Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223:154–162CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Nakagohri T, Kinoshita T, Konishi M, Inoue K, Takahashi S (2003) Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 186:149–153CrossRefPubMedGoogle Scholar
  24. 24.
    Harrison LE, Klimstra DS, Brennan MF (1996) Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindicationfor resection? Ann Surg 224:342–347, discussion347-9CrossRefPubMedCentralPubMedGoogle Scholar
  25. 25.
    Worni M, Castleberry AW, Clary BM, Gloor B, Carvalho E, Jacobs DO et al (2012) Concomitant vascular reconstruction during pancreatectomy for malignant disease: a propensity score-adjusted, population-based trend analysis involving 10 206 patients. Arch Surg 1–8Google Scholar
  26. 26.
    Fukuda S, Oussoultzoglou E, Bachellier P, Rosso E, Nakano H, Audet M et al (2007) Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg 142:172–179, discussion 180CrossRefPubMedGoogle Scholar
  27. 27.
    Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Buchler MW et al (2011) Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and metaanalysis. Ann Surg 254:882–893CrossRefPubMedGoogle Scholar
  28. 28.
    Nakayama Y, Yamashita Y, Kadota M, Takahashi M, Kanemitsu K, Hiraoka T et al (2001) Vascular encasement by pancreatic cancer: correlation of CT findings with surgical and pathologic results. J Comput Assist Tomogr 25:337–342CrossRefPubMedGoogle Scholar
  29. 29.
    Li H, Zeng MS, Zhou KR, Jin DY, Lou WH (2005) Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion. J Comput Assist Tomogr 29:170–175CrossRefPubMedGoogle Scholar
  30. 30.
    Katz MH, Fleming JB, Bhosale P, Varadhachary G, Lee JE, Wolff R et al (2012) Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer 118:5749–5756CrossRefPubMedGoogle Scholar
  31. 31.
    Evans DB, Farnell MB, Lillemoe KD et al (2009) Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16(7):1736–1744CrossRefPubMedGoogle Scholar
  32. 32.
    Papavasiliou P, Chun YS, Hoffman JP (2013) How to define and manage borderline resectable pancreatic cancer. Surg Clin N Am 93:663–674CrossRefPubMedGoogle Scholar
  33. 33.
    La Torre M, Nigri G, Cavallini M, Mercantini P, Ziparo V, Ramacciato G (2012) The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma. Ann Surg Oncol 19:2917–2923CrossRefPubMedGoogle Scholar
  34. 34.
    Abrams RA, Lowy AM, O’Reilly EM et al (2009) Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16(7):1751–1756CrossRefPubMedGoogle Scholar
  35. 35.
    Harish Lavu H, Yeo CJ (2011) Current surgical therapy. Periampullary cancer, 10th edn. Elsevier Saunders, PhiladelphiaGoogle Scholar
  36. 36.
    Katz MH, Fleming JB, Pisters PW et al (2008) Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy. Ann Surg 248(6):1098–1102CrossRefPubMedGoogle Scholar
  37. 37.
    Nagakawa T, Kayahara M, Ohta T et al (1991) Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer. Int J Pancreatol 10:113–119PubMedGoogle Scholar
  38. 38.
    Cusack JC Jr, Fuhrman GM, Lee JE et al (1994) Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. Am J Surg 168(4):352–354CrossRefPubMedGoogle Scholar
  39. 39.
    Tseng JF, Tamm EP, Lee JE et al (2006) Venous resection in pancreatic cancer surgery. Best Pract Res Clin Gastroenterol 20(2):349–364CrossRefPubMedGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2015

Authors and Affiliations

  • Bhargava Mullapudi
    • 1
  • Patrick J. Hawkes
    • 1
  • Asish Patel
    • 1
  • Chandrakanth Are
    • 1
  • Subhasis Misra
    • 2
    Email author
  1. 1.Department of SurgeryUniversity of Nebraska Medical CenterOmahaUSA
  2. 2.Department of SurgeryTexas Tech University Health Sciences CenterAmarilloUSA

Personalised recommendations